LMNLLiminal BioSciences Inc.

Nasdaq liminalbiosciences.com


$ 8.50 $ 0.01 (0.12 %)    

Monday, 25-Sep-2023 15:26:32 EDT
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 8.5
$ 8.50
$ 0.00 x 0
$ 0.00 x 0
$ 8.50 - $ 8.50
$ 3.10 - $ 8.50
5,095
na
263.86M
$ 32.73
$ 574.05
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 liminal-biosciences-receives-final-court-order-for-plan-of-arrangement-with-structured-alpha-lp

Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), is pleased to announce that i...

 liminal-biosciences-reports-q2-financial-results-2023-cash-and-cash-equivalents-were-193m-at-june-30-2023

Second Quarter Ended June 30th 2023 Financial Results All figures presented in this section are in Canadian dollars. Cash a...

 why-lucid-group-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to preven...

 liminal-biosciences-stock-gains-40-today---heres-why

Liminal BioSciences Inc (NASDAQ: LMNL) shares are trading higher after Structured Alpha, a fund managed by Thomvest Asset Manag...

 liminal-biosciences-enters-arrangement-agreement-with-structured-alpha-lp-minority-shareholders-to-receive-850-in-cash-per-share-in-go-private-transaction

SALP will acquire all of the issued and outstanding common shares of Liminal BioSciences (the "Common Shares") that it ...

 the-special-committee-of-the-board-of-directors-of-liminal-biosciences-retains-an-independent-financial-advisor-in-response-to-unsolicited-non-binding-transaction-proposal

 Liminal BioSciences Inc. (NASDAQ:LMNL) ("Liminal BioSciences" or the "Company"), re-confirms that the board of...

 10-short-squeeze-stocks-to-watch-getty-images-bullfrog-ai-and-a-stock-moving-up-1687-positions-on-leaderboard

Potential shorts squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the ...

 why-seachange-international-shares-are-trading-higher-by-17-here-are-20-stocks-moving-premarket

Gainers

 dow-rises-80-points-marketaxess-holdings-shares-slide

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Wednesday. The Dow traded u...

 why-kura-sushi-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. ...

 nasdaq-tumbles-150-points-liminal-biosciences-shares-spike-higher

U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite dropping around 150 points on Wednesday. The...

 markets-mixed-us-trade-deficit-widens-in-february

U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping more than 50 points on Wednesday. Following the mark...

 liminal-biosciences-confirms-receipt-of-750-per-share-unsolicited-non-binding-transaction-proposal

The Board of Directors of the company received a non-binding proposal from Structured Alpha LP. SALP currently owns 1,987,622 c...

 thomvest-asset-management-ltd-makes-non-binding-offer-to-acquire-outstanding-shares-of-liminal-biosciences-inc-other-than-64-owned-by-structured-alpha-lp-for-750share

Thomvest Asset Management Ltd. ("Thomvest") today announced that it has made a non-binding, all cash proposal (the "...

 liminal-biosciences-q4-eps-172-up-from-290-yoy-sales-17943k-down-from-23800k-yoy

Liminal Biosciences (NASDAQ:LMNL) reported quarterly losses of $(1.72) per share. This is a 40.69 percent increase over losses ...

 liminal-biosciences-q4-2022-net-loss-c42m

Liminal Biosciences (NASDAQ:LMNL) will report on Q4 2022.

 earnings-scheduled-for-march-15-2023

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share...

 liminal-biosciences-regains-compliance-with-nasdaq-minimum-bid-price-requirement

Liminal BioSciences Inc. (NASDAQ:LMNL) ("Liminal BioSciences" or the "Company"), announced that it has received...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION